This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

Analysts Offer Insights on Real Estate Companies: Iron Mountain (IRM) and Lineage, Inc. (LINE)

Tipranks - Thu Jun 18, 6:54AM CDT

There’s a lot to be optimistic about in the Real Estate sector as 2 analysts just weighed in on Iron Mountain (IRM) and Lineage, Inc. (LINE) with bullish sentiments.

Claim 55% Off TipRanks

Iron Mountain (IRM)

In a report released today, Tobey Sommer from Truist Financial maintained a Buy rating on Iron Mountain. The company’s shares closed last Tuesday at $128.21, close to its 52-week high of $130.24.

According to TipRanks.com, Sommer is a 4-star analyst with an average return of 4.5% and a 53.2% success rate. Sommer covers the Industrial Goods sector, focusing on stocks such as Andersen Group, Inc. Class A, Amentum Holdings, Inc., and GFL Environmental. ;'>

The word on The Street in general, suggests a Strong Buy analyst consensus rating for Iron Mountain with a $140.57 average price target, which is a 9.3% upside from current levels. In a report issued on June 15, Goldman Sachs also reiterated a Buy rating on the stock with a $149.00 price target.

See Insiders’ Hot Stocks on TipRanks >>

Lineage, Inc. (LINE)

In a report released today, Michael Lewis from Truist Financial maintained a Buy rating on Lineage, Inc., with a price target of $46.00. The company’s shares closed last Tuesday at $42.83.

According to TipRanks.com, Lewis is a 5-star analyst with an average return of 9.8% and a 65.1% success rate. Lewis covers the NA sector, focusing on stocks such as SmartStop Self Storage REIT, Inc., Easterly Government Properties, and American Healthcare REIT, Inc. ;'>

The word on The Street in general, suggests a Hold analyst consensus rating for Lineage, Inc. with a $43.91 average price target, implying a 1.1% upside from current levels. In a report issued on June 11, TipRanks – DeepSeek also upgraded the stock to Buy with a $49.00 price target.

Read More on IRM:

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.